Annual Total Liabilities
$9.20 M
-$5.67 M-38.12%
March 31, 2024
Summary
- As of February 8, 2025, SXTC annual total liabilities is $9.20 million, with the most recent change of -$5.67 million (-38.12%) on March 31, 2024.
- During the last 3 years, SXTC annual total liabilities has fallen by -$9.39 million (-50.52%).
- SXTC annual total liabilities is now -50.52% below its all-time high of $18.59 million, reached on March 31, 2021.
Performance
SXTC Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$9.20 M
-$315.00 K-3.31%
March 31, 2024
Summary
- As of February 8, 2025, SXTC quarterly total liabilities is $9.20 million, with the most recent change of -$315.00 thousand (-3.31%) on March 31, 2024.
- Over the past year, SXTC quarterly total liabilities has dropped by -$5.67 million (-38.12%).
- SXTC quarterly total liabilities is now -50.52% below its all-time high of $18.59 million, reached on March 31, 2021.
Performance
SXTC Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
SXTC Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.1% | -38.1% |
| 3 y3 years | -50.5% | -38.1% |
| 5 y5 years | +44.5% | -38.1% |
SXTC Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -50.5% | at low | -46.3% | +26.1% |
| 5 y | 5-year | -50.5% | +44.5% | -50.5% | +66.5% |
| alltime | all time | -50.5% | +157.0% | -50.5% | +130.4% |
China SXT Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | $9.20 M(-38.1%) | $9.20 M(-3.3%) |
| Sep 2023 | - | $9.51 M(-36.0%) |
| Mar 2023 | $14.86 M(-13.2%) | $14.86 M(+103.8%) |
| Sep 2022 | - | $7.29 M(-57.4%) |
| Mar 2022 | $17.12 M(-7.9%) | $17.12 M(+92.8%) |
| Sep 2021 | - | $8.88 M(-52.2%) |
| Mar 2021 | $18.59 M | $18.59 M(+236.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $5.52 M(-55.1%) |
| Mar 2020 | $12.30 M(+93.3%) | $12.30 M(+5.7%) |
| Sep 2019 | - | $11.64 M(+82.9%) |
| Mar 2019 | $6.36 M(+45.5%) | $6.36 M(+59.4%) |
| Sep 2018 | - | $3.99 M(-8.7%) |
| Mar 2018 | $4.37 M(+22.2%) | $4.37 M |
| Mar 2017 | $3.58 M | - |
FAQ
- What is China SXT Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for China SXT Pharmaceuticals?
- What is China SXT Pharmaceuticals annual total liabilities year-on-year change?
- What is China SXT Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for China SXT Pharmaceuticals?
- What is China SXT Pharmaceuticals quarterly total liabilities year-on-year change?
What is China SXT Pharmaceuticals annual total liabilities?
The current annual total liabilities of SXTC is $9.20 M
What is the all time high annual total liabilities for China SXT Pharmaceuticals?
China SXT Pharmaceuticals all-time high annual total liabilities is $18.59 M
What is China SXT Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, SXTC annual total liabilities has changed by -$5.67 M (-38.12%)
What is China SXT Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of SXTC is $9.20 M
What is the all time high quarterly total liabilities for China SXT Pharmaceuticals?
China SXT Pharmaceuticals all-time high quarterly total liabilities is $18.59 M
What is China SXT Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, SXTC quarterly total liabilities has changed by -$5.67 M (-38.12%)